Showing posts with label biochemical markers. Show all posts
Showing posts with label biochemical markers. Show all posts

Thursday, 14 March 2024

Biochemical Markers of Diabetic Nephropathy: Selection and Future Perspectives | Chapter 1 | Advancement and New Understanding in Medical Science Vol. 8

Diabetic nephropathy (DN) is the primary reason for end-stage renal disease. As diabetes mellitus is an inflammatory disease that affects the hemodynamic and metabolic axis, therefore identifying inflammatory biomarkers early on is crucial to minimizing the disease's associated consequences. The bad prognosis of terminal stages of Diabetic kidney disease (DKD), necessitating kidney transplant or else early mortality, can be postponed with early detection and optimization of currently available diagnostic alternatives. This chapter provides an overview of biochemical biomarkers being widely used as diagnostic and prognostic tools for diabetic nephropathy.


Author(s) Details:

Dhama A,
Department of Biochemistry, NC Medical College and Hospital, Israna, Panipat, India.

Chahal A,
Department of Biochemistry, PGIMS, Rohtak, India.

Please see the link here: https://stm.bookpi.org/ANUMS-V8/article/view/13514

Wednesday, 14 June 2023

Biochemical Changes as Early Markers of Adverse Neuro-developmental Outcome in Multisystem Inflammatory Syndrome-Neonate | Chapter 15 | New Advances in Medicine and Medical Science Vol. 5

 This study was understood to identify the biochemical gravestones during neonatal period that correlate accompanying neurodevelopmental outcome, so that even when hide and early imaging gives no clues, clinicians maybe on guard about later onset of delays. The multisystem angering syndrome-Newborn (MISC-N) occurs in male babies innate to Covid positive founders and is a sign that the mother has Covid-19, making pregnant mothers and newborns particularly naive to it. Sixteen newborns born to Covid positive founders were enrolled prospectively in this place study after earning informed consent at 40 weeks of gestational age. Newborns with MIS-N accompanying proven agent for negating the effect of an infection or poison titers and newborns with positive Covid experiment for the mother at transfer were included in the study. Demographic description, treatment details and biochemical limits were analyzed accompanying neurodevelopmental follow-up. 25% mothers taken 2 doses of Covid vaccine; 50% had oligohydromnios and 75% taken antenatal steroids.87.5% were preterm of which 62.5% required surfactant accompanying ventilator support and 75% necessary ionotropic support. Significant association was erect between the antibody level and D-dimer admit the ferritin and LDH levels of the baby (p < 0.05); gestational age with LDH and D-dimer levels (p < 0.05) and Covid often causing illness level of the baby vs the duration of ventilator necessity (P-value-0.0009). Babies innate to Covid positive founders should be included in the extreme-risk newborn type and should be strictly listened and followed up for early labeling of neurodevelopmental and neurobehavioral problems and early stimulation and attack. D-dimer values of babies were absolutely associated with two together maternal antibody and D-dimer levels. Neurodevelopmental effect done at 6 months of rectified gestational age showed 37.5% were normal, 37.5% hypertonic and 25% hypotonic. HINE score was beneath 60 in 62.5%. Development assessment utilizing Bayley-III showed a delay in the engine domain (62.5%), cognitive rule (56.25%) and language rule (62.5%). Hence, it should be born in mind that neurodevelopmental questions occur in babies innate to Covid positive mothers and endure be stratified as “extreme risk”. Anticipatory guidance bear be given to prospective inventors for preterm care. Covid antibody titre and D-dimer levels can help to predict the NICU stay, ventilator necessity and the adverse neuro-enlightening outcomes in these babies.

Author(s) Details:

Devika Sanil Kumar,
Department of Research and Development, Saveetha Medical College and Hospital, Chennai, India.

Lal Devayani Vasudevan Nair,
Department of Pediatrics, Saveetha Medical College and Hospital, Chennai, India.

Perumalsathya Sankaranarayanan,
Department of Pediatrics, Saveetha Medical College and Hospital, Chennai, India.

Harshitha Shanmuganathan,
Department of Pediatrics, Saveetha Medical College and Hospital, Chennai, India.

Santosh Kamalakannan,
Department of Neonatology, Saveetha Medical College and Hospital, Chennai, India.

Please see the link here: https://stm.bookpi.org/NAMMS-V5/article/view/10875

Thursday, 25 August 2022

Recent Biochemical Markers for Cardiovascular Diseases: Diagnostic and Prognostic Implications | Chapter 7 | Current Practice in Medical Science Vol. 11

 The major cause of death and morbidity worldwide is cardiovascular disease. A better prognosis may result from early detection of a potential CVD risk and early care. Cardiac biomarkers are crucial in the early diagnosis within the "golden period" in order to carry out an early intervention and maybe undo cardiac damage. The potential biochemical markers linked to heart tissue, inflammation, and underlying metabolic processes have been identified in numerous studies and may help in the clinical evaluation of the population at risk or who is at vulnerability. This chapter gives a general overview of the cardiac biomarkers that are frequently utilised for CVD risk assessment as diagnostic and prognostic tools.


Author(s) Details:

Deepika Dalal,
Department of Biochemistry, N.C. Medical College and Hospital, Israna, Haryana, India.

Ashish Kumar Malik,
Department of Psychiatry, N.C. Medical College and Hospital, Israna, Haryana, India.

Anjali Dhama,
Department of Biochemistry, N.C. Medical College and Hospital, Israna, Haryana, India.

Veena Singh Ghalaut,
Department of Biochemistry, N.C. Medical College and Hospital, Israna, Haryana, India.

Please see the link here: https://stm.bookpi.org/CPMS-V11/article/view/8031